High-speed combat drone production starts at new US Anduril plant in days
Anduril's Arsenal-1 facility begins production of three combat systems simultaneously, signaling manufacturing scale capability amid $20B Army counter-UAS contract award.
- $20B U.S. Army counter-UAS contract (10 years)
- $6.3B Total fundraising
- $1B Arsenal-1 facility investment
- 1.7M sq ft Arsenal-1 production facility (Pickaway County, Ohio)
- HQ
- Costa Mesa, California, United States
- Founded
- 2017
- Employees
- 1000
- Products
- Fury (YFQ-44A)·Roadrunner·Barracuda·Lattice
Arsenal-1 Goes Live: Anduril’s Production Start Is a Stress Test, Not a Victory Lap
The significance of Anduril’s Fury production line coming online at Arsenal-1 is not that a drone is being built — it’s that a nine-year-old company is now being judged by factory output rather than fundraising rounds.
Arsenal-1, the $1 billion, approximately 1.7 million square-foot complex in Pickaway County, Ohio, is simultaneously producing three distinct systems: the YFQ-44A Fury collaborative combat aircraft, the Roadrunner autonomous interceptor, and the Barracuda cruise missile. That multi-product simultaneous ramp is operationally ambitious by any standard, and it arrives against a backdrop of extraordinary contract momentum. Within the past week alone, the U.S. Army awarded Anduril a $20 billion, 10-year counter-UAS enterprise contract — the largest published C-UAS contract on record — followed by an $87 million JIATF-401 task order for Lattice as a tactical C2 platform. The $250 million Pentagon buy of 500 Roadrunner interceptors, announced in January 2025, provides the near-term production anchor that makes Arsenal-1’s economics defensible. The contract pipeline is real; the question is whether the factory can absorb it.
The competitive stakes for Fury specifically are high and time-sensitive. Anduril holds one of five USAF Collaborative Combat Aircraft development slots — alongside established primes with decades of production infrastructure — and a downselect to a program of record remains pending. The production start at Arsenal-1 is a deliberate signal to the Air Force that Anduril can manufacture at scale, not just prototype. Lattice, meanwhile, is doing parallel work: the Space Force selected it for surveillance networks, the Army’s NGC2 architecture now integrates it, and the $87 million JIATF-401 award positions it as the software layer beneath the $20 billion enterprise vehicle. If Lattice becomes the C2 standard across counter-UAS programs, it creates integration dependency that persists regardless of which hardware platforms win individual downselects. The acquisition of ExoAnalytic Solutions — operating more than 400 telescopes for space domain awareness — announced March 11 suggests Anduril is simultaneously extending Lattice’s domain coverage upward while Arsenal-1 scales production downward.
The bear case here is straightforward and should not be dismissed: ramping three complex weapons systems simultaneously in a new facility, with an unverified revenue base of approximately $1 billion and a private valuation that ranges from $14 billion (Series F, verified) to figures above $60 billion (aggregator estimates, unverified), leaves almost no margin for schedule slip. A six-month delay in Fury production would arrive precisely when the USAF is evaluating downselect candidates. The U.S. Northern Command’s confirmed counter-drone engagement at a strategic installation during Operation Epic Fury on March 19 — the same day as this production announcement — underscores that operational demand is not theoretical. But demand does not guarantee execution.
BOTTOM LINE
Procurement officers and program managers tracking CCA and counter-UAS should treat Arsenal-1’s production start as the opening of a 90-day execution window that will either validate Anduril’s industrial thesis or expose it — monitor Fury unit delivery confirmations and any USAF CCA downselect signals before Q3 2026.
Confidence: MODERATE — Contract awards and facility existence are independently verified, but simultaneous multi-system production rates, actual unit deliveries, and Fury’s competitive position in the CCA downselect remain unconfirmed by audited or official program data.
Product Portfolio — Anduril
Signal Activity — Anduril
Deal History — Anduril
Competitive Positioning — Anduril